Navigation Links
Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
Date:6/22/2013

PARIS, June 22, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the first Phase 3 study results (EDITION I) for its investigational new insulin U300 showed equivalent blood sugar control with fewer night-time low blood sugar events compared to Lantus® (insulin glargine [rDNA origin] injection). The company also announced topline results of a second Phase 3 study (EDITION II) for new insulin U300 that also demonstrated similar blood sugar reduction while fewer patients experienced night-time low blood sugar events compared with Lantus®.

(Logo: http://photos.prnewswire.com/prnh/20110624/NY25833LOGO )

These results are from EDITION I and EDITION II respectively and are part of the EDITION Phase 3 clinical program evaluating the efficacy and safety of the investigational new insulin U300 in people with diabetes.  The EDITION I data was presented at the 73rd Scientific Sessions of the American Diabetes Association.

"To properly manage diabetes, it is critical to control blood sugar and to reduce the risk of low blood sugar events, especially at night," said Matthew Riddle, Professor of Medicine, Division of Endocrinology/Diabetes/Clinical Nutrition, Oregon Health and Science University, U.S., and Principal Investigator for the EDITION I study. "I am encouraged by these findings, and look forward to the results of the full Phase 3 EDITION program, which will further reveal how this investigational basal insulin may help people living with diabetes."

EDITION IAs the first study of the EDITION Phase 3 program, EDITION I evaluated the efficacy and safety of investigational new insulin U300, vs. Lantus® in people with type 2 diabetes using basal pl
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sanofi Announces Positive Phase 3 Data for Once-Daily Lixisenatide for Type 2 Diabetes
2. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
3. Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
4. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
5. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
6. Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)
7. NextBio Announces Translational Medicine Partnership with Sanofi
8. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
9. Sanofi US Offers a New Way to Say "Thank You" and Recognize the Unsung Heroes of Severe Allergy Awareness
10. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Metanome, Inc. , a Houston -based ... the genomic sequencing provider for Seres Health,s ( ... SER 109, an Ecobiotic® therapeutic for the treatment of ... Metanome has provided genomic sequencing services in ... genomic characterization has enabled the study of the microbiota ...
(Date:10/25/2014)... , Oct. 24, 2014 Best Practices ... Affairs leaders with a forum for sharing insights ... has developed a mechanism for creating and sharing ... discuss key findings from the Medical Affairs Consortium ... the analysis for the first roundtable of the ...
(Date:10/22/2014)... N.J. , Oct. 22, 2014  Rescheduling ... major transformation in the pain market, according to ... Insights, Inc., a firm providing market research and ... Photo - http://photos.prnewswire.com/prnh/20141021/153440 ... scheduling change for hydrocodone combination products from Schedule ...
Breaking Medicine Technology:Metanome Selected as Metagenomics Provider for Seres Health Clinical Trial 2Strong Participation in Best Practices' Medical Affairs Consortium Survey 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3
(Date:10/26/2014)... Aliso Viejo, California (PRWEB) October 26, 2014 ... have announced the release of the Bubble Babies theme for ... have given our users many choices and the Bubble Babies ... Austin, CEO of Pixel Film Studios. “Bubble Babies theme is ... love.” , Bubble Babies is a fun and professional ...
(Date:10/25/2014)... Recently, the famous review website, Top10BestSEOHosting.com, ... 2014. . According to the site, GoDaddy, Bluehost ... in the world. “Nowadays, Joomla hosting is a ... from hosting. The account owner is allowed to ... websites under a specific name, brand or company,” ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 Triton ... today announced Dr. Xun Wang has ... Research & Development. , Triton has developed a patented ... algae-based proteins. According to Dr. Wang, the platform uses ... expression systems. He says, “Algae are unique because they ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 The global ... CAGR of 7.6%, to reach $50.4 billion by 2018 ... healthcare systems industry, and pharmaceutical industry are driving the ... model to enhance their focus on core business, reduce ... and trained staff (further reducing hiring and training costs), ...
(Date:10/25/2014)... Hartford, CT (PRWEB) October 25, 2014 Background: ... for Addiction Recovery (CCAR). He is a pioneer in the ... 30-year career in Connecticut's state treatment system and when he ... had nagged him while in public service. ... are making critical decisions concerning them? , 2. Can ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios announced today the release of the Bubble Babies theme for Final Cut Pro X 2Health News:Top10BestSEOHosting.com: GoDaddy, Bluehost And Hostgator Are Among The Most Excellent Suppliers In The World 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2
... New Manager,s amendment holds tax burdens that will raise ... Dec. 20 Yesterday, Senator Reid released his Manager,s ... in the U.S. Senate. One provision in the amendment involved ... the health insurance industry. As the Congressional Budget Office has ...
... ... LLC recently named two QHR management clients to its “Top 100 ... Madison, Iowa), a QHR management client since 1982, and Monroe County ... by the company, which specializes in providing hospitals and other healthcare-related ...
... ... retested nearly 3,000 breast cancer specimens from the Province of Quebec following an inquiry ... some patients. , ... (PRWEB) December 20, 2009 -- Seattle-based PhenoPath Laboratories served as the reference laboratory for ...
... Federal government must not expand its role enabling abortions ... until problems remedied , Protection of life, conscience ... WASHINGTON, Dec. 19 The Senate health reform bill should ... of Galveston-Houston, Bishop William Murphy of Rockville Centre, New York, ...
... , WASHINGTON, Dec. 19 Official statement of Americans ... Leader Reid,s amendment to the Senate health care bill absolutely fails ... law and policy. It does not prevent federal funding of ... care providers who choose to exercise their rights of conscience, and ...
... , , Additional $15 ... WASHINGTON, Dec. 19 Today, the United States Congress approved an ... of the fiscal year 2010 Department of Defense (DOD) Appropriations package. ... appropriated to date for the new program since it was launched ...
Cached Medicine News:Health News:Anthem Blue Cross and Blue Shield In Missouri Urges Missouri Senators Claire McCaskill and Christopher S. Bond to Not Support the Current Senate Health Care Reform Legislation 2Health News:Anthem Blue Cross and Blue Shield In Missouri Urges Missouri Senators Claire McCaskill and Christopher S. Bond to Not Support the Current Senate Health Care Reform Legislation 3Health News:QHR Hospital Clients Fort Madison Community Hospital, Monroe County Hospital Named to “Best in Value” Top 100 List 2Health News:Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast Cancer Inquiry 2Health News:Seattle-based PhenoPath Laboratories Retests Nearly 3,000 Breast Cancer Specimens from Quebec Breast Cancer Inquiry 3Health News:Health Reform Bill Needs More Work Despite New Language on Abortion, Say Catholic Bishops 2Health News:Health Reform Bill Needs More Work Despite New Language on Abortion, Say Catholic Bishops 3Health News:Health Reform Bill Needs More Work Despite New Language on Abortion, Say Catholic Bishops 4Health News:Americans United for Life Action: 'Senate Health Care Bill Absolutely Fails To Meet Abortion and Life Protections.' 2Health News:Americans United for Life Action: 'Senate Health Care Bill Absolutely Fails To Meet Abortion and Life Protections.' 3Health News:Lung Cancer Alliance Hails New Federal Funding for Lung Cancer Research 2Health News:Lung Cancer Alliance Hails New Federal Funding for Lung Cancer Research 3
... high-quality light guide cables work in conjunction ... optimal brightness during a number of procedures. ... you the flexibility and ease-of-use necessary to ... fully-autoclavable so they can be easily cleaned ...
... line of affordable, high-quality light guide cables ... sources to provide optimal brightness during a ... durable design give you the flexibility and ... And each is fully-autoclavable so they can ...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
ACMI™ offers an assortment of fiberoptic light guides, high transmission autoclavable fiberoptic light guides, and light guide adapters to connect our scopes to other manufacturers' light sourc...
Medicine Products: